Pneumolysin toxin holds promise for developing therapies against Streptococcus pneumoniae

In a recent study published in the journal PLoS ONE, researchers in Spain performed a systematic review of pneumolysin (PLY) toxin as a molecular target to develop novel therapeutics against Streptococcus pneumoniae.

Related Keywords

Spain ,Kateryna Kon , ,Industry Focus ,Pneumolysin ,Streptococcus Pneumoniae ,Toxin ,Antibodies ,Poptosis ,Children ,Cholesterol ,Docosahexaenoic Acid ,Exosomes ,Inflammation ,Inase ,Embrane ,Meningitis ,Amorphology ,Necroptosis ,Otitis Media ,Eptides ,Pneumonia ,Protein ,Eceptor ,Septicemia ,Sinusitis ,Herapeutics ,